CAR T-Cell Therapy

Overview

CAR T-cell therapy is a revolutionary cancer treatment involving the genetic engineering of a patient's T cells to specifically target and destroy cancer cells. This groundbreaking immunotherapy has shown remarkable success in treating certain blood cancers.

Tata Memorial Centre, Mumbai, and IIT Bombay developed the indigenous CAR T-cell therapy, NexCAR19, in collaboration with ImmunoACT. It is the world's most affordable CAR T-cell therapy, making it accessible to many patients.

Key Benefits

• Highly effective for certain blood cancers
• One-time treatment with long-lasting effects
• Personalized therapy using patient's own cells
• Potential for complete remission in cases resistant to other treatments

Treatment Process

1. 1

   Collection of patient's T cells through apheresis

2. 2

   Genetic modification of T cells in the laboratory

3. 3

   Expansion of modified T cells

4. 4

   Infusion of CAR T cells back into the patient

5. 5

   Monitoring and follow-up care

Treated Conditions